OSI-774 in advanced Esophageal Cancer: A phase II study.

被引：0
|
作者：
Radovich, D [1 ]
Kelsen, D [1 ]
Shah, M [1 ]
Klimstra, D [1 ]
Gavin, SG [1 ]
Munoz, D [1 ]
Ilson, DH [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4077
引用
收藏
页码：332S / 332S
页数：1
相关论文
共 50 条
  • [1] Phase II study of erlotinib (OSI-774) in patients with advanced hepatocellular cancer
    Philip, PA
    Mahoney, MR
    Allmer, C
    Thomas, J
    Pitot, HC
    Kim, G
    Donehower, RC
    Fitch, T
    Picus, J
    Erlichman, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (27) : 6657 - 6663
  • [2] Phase II study of OSI-774 in patients with metastatic colorectal cancer
    Townsley, C
    Major, P
    Siu, LL
    Dancey, J
    Vincent, M
    Pond, G
    MacLean, M
    Moore, MJ
    Oza, AM
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S57 - S57
  • [3] Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer
    C A Townsley
    P Major
    L L Siu
    J Dancey
    E Chen
    G R Pond
    T Nicklee
    J Ho
    D Hedley
    M Tsao
    M J Moore
    A M Oza
    British Journal of Cancer, 2006, 94 : 1136 - 1143
  • [4] Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer
    Townsley, CA
    Major, P
    Siu, LL
    Dancey, J
    Chen, E
    Pond, GR
    Nicklee, T
    Ho, J
    Hedley, D
    Tsao, M
    Moore, MJ
    Oza, AM
    BRITISH JOURNAL OF CANCER, 2006, 94 (08) : 1136 - 1143
  • [5] A phase II Study of OSI-774 in unresectable hepatocellular carcinoma.
    Thomas, MB
    Faria, S
    Tamm, E
    Rashid, A
    Charnsangavej, C
    Dancey, J
    Abbruzzese, J
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6092S - 6092S
  • [6] Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma
    J. F. de Groot
    M. R. Gilbert
    K. Aldape
    K. R. Hess
    T. A. Hanna
    S. Ictech
    M. D. Groves
    C. Conrad
    H. Colman
    V. K. Puduvalli
    V. Levin
    W. K. A. Yung
    Journal of Neuro-Oncology, 2008, 90 : 89 - 97
  • [7] Phase II trial of erlotinib (OSI-774) in patients with hepatocellular or biliary cancer.
    Philip, PA
    Mahoney, M
    Thomas, J
    Pitot, H
    Donehower, R
    Kim, G
    Picus, J
    Fitch, T
    Geyer, S
    Erlichman, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 319S - 319S
  • [8] Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma
    de Groot, J. F.
    Gilbert, M. R.
    Aldape, K.
    Hess, K. R.
    Hanna, T. A.
    Ictech, S.
    Groves, M. D.
    Conrad, C.
    Colman, H.
    Puduvalli, V. K.
    Levin, V.
    Yung, W. K. A.
    JOURNAL OF NEURO-ONCOLOGY, 2008, 90 (01) : 89 - 97
  • [9] Phase I and II study of OSI-774 and docetaxel in squamous cell carcinoma of the head and neck (SCCHN).
    Rhoades, CA
    Kraut, E
    Schuller, D
    Zhang, Y
    Chan, K
    Lang, K
    Eng, C
    Grever, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 498S - 498S
  • [10] Phase I and II study of OSI-774 and docetaxel in squamous cell carcinoma of the head and neck (SSCHN)
    Rhoades, C
    Kraut, E
    Schuller, D
    Chan, K
    Lang, K
    Eng, C
    Grever, M
    Richard, J
    LUNG CANCER, 2004, 46 : S79 - S79
12345